Search details
1.
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
; 120(11): e2219523120, 2023 03 14.
Article
in English
| MEDLINE | ID: mdl-36893269
2.
RNAi-based modulation of IFN-γ signaling in skin.
Mol Ther
; 30(8): 2709-2721, 2022 08 03.
Article
in English
| MEDLINE | ID: mdl-35477658
3.
HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme.
BMC Public Health
; 19(1): 13, 2019 Jan 03.
Article
in English
| MEDLINE | ID: mdl-30606134
4.
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
Clin Infect Dis
; 67(3): 420-429, 2018 07 18.
Article
in English
| MEDLINE | ID: mdl-29538636
5.
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.
N Engl J Med
; 373(9): 795-807, 2015 Aug 27.
Article
in English
| MEDLINE | ID: mdl-26192873
6.
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.
J Virol
; 91(15)2017 08 01.
Article
in English
| MEDLINE | ID: mdl-28539449
7.
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.
PLoS Pathog
; 12(8): e1005745, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-27561082
8.
Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database.
Nephrology (Carlton)
; 23(8): 778-786, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-28703924
9.
Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
BMC Public Health
; 18(1): 210, 2018 02 02.
Article
in English
| MEDLINE | ID: mdl-29394918
10.
Correction: expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in new South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
BMC Public Health
; 18(1): 297, 2018 02 28.
Article
in English
| MEDLINE | ID: mdl-29490635
11.
The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
BMC Med
; 15(1): 145, 2017 08 04.
Article
in English
| MEDLINE | ID: mdl-28774293
12.
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.
PLoS Pathog
; 11(7): e1005000, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-26133551
13.
HIV care in Yangon, Myanmar; successes, challenges and implications for policy.
AIDS Res Ther
; 14(1): 10, 2017 Mar 04.
Article
in English
| MEDLINE | ID: mdl-28257647
14.
Improved adipose tissue function with initiation of protease inhibitor-only ART.
J Antimicrob Chemother
; 71(11): 3212-3221, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27516476
15.
Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
J Infect Dis
; 211(4): 529-38, 2015 Feb 15.
Article
in English
| MEDLINE | ID: mdl-25170105
16.
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial.
Clin Infect Dis
; 60(7): 1026-32, 2015 Apr 01.
Article
in English
| MEDLINE | ID: mdl-25501988
17.
Human antigen-specific CD4⺠CD25⺠CD134⺠CD39⺠T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.
Eur J Immunol
; 44(6): 1644-61, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24752698
18.
HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
J Virol
; 88(6): 3516-26, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24403590
19.
Combination ART: are two drugs as good as three?
Lancet
; 391(10123): 817-819, 2018 03 03.
Article
in English
| MEDLINE | ID: mdl-29310898
20.
The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection.
Eur J Immunol
; 43(2): 510-20, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23129528